← Mechanisms of action
Ebolavirus
ORGANISMEbolavirus
Drugs acting on this target (36)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ANSUVIMAB (Ebanga) | Antagonist | approved | mAb | Ebolavirus antagonist |
| atoltivimab (Inmazeb) | Antagonist | approved | mAb | Ebolavirus antagonist |
| gamezumab | Antagonist | experimental | mAb | Ebolavirus antagonist |
| maftivimab (Inmazeb) | Antagonist | approved | mAb | Ebolavirus antagonist |
| odesivimab (Inmazeb) | Antagonist | approved | mAb | Ebolavirus antagonist |
| avi-6002 | Antisense inhibitor | experimental | Nucleic acid | Ebolavirus antisense inhibitor |
| tkm-100201 | Antisense inhibitor | experimental | Nucleic acid | Ebolavirus antisense inhibitor |
| tkm-100802 | Antisense inhibitor | experimental | Nucleic acid | Ebolavirus antisense inhibitor |
| ad26.filo | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| ad26.zebov (Zabdeno) | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| ad5-ebov | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| bpsc-1001 vaccine | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| cad3-zebov | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| ebola vaccine (Ervebo) | Immunity, active | approved | Vaccine | Ebolavirus immunity, active |
| ebov gp vaccine | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| gsk3390107a | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| hpiv3/δhnf/ebovz gp vaccine | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| ino-4201 | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| ino-4202 | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| ino-4212 | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| mva-bn-filo (Mvabea) | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| rvsv | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| rvsv-sudv | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| rvsvdg-zebov-gp | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vrc-eboadc076-00-vp | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vrc-eboadv018-00-vp | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vrc-ebodna012-00-vp | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vrc-ebodna023-00-vp | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vrc-ebomva079-00-vp | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vsv-zebov | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| vsvg-zebov | Immunity, active | experimental | Vaccine | Ebolavirus immunity, active |
| gamemab | Immunity, passive | experimental | mAb | Ebolavirus immunity, passive |
| regn-eb3 | Immunity, passive | experimental | mAb | Ebolavirus immunity, passive |
| vrc-ebomab092-00-ab | Immunity, passive | experimental | mAb | Ebolavirus immunity, passive |
| zmapp | Immunity, passive | experimental | Botanical | Ebolavirus immunity, passive |
| avi-7537 | Inhibitor | experimental | Nucleic acid | Ebolavirus inhibitor |